← Insider buys
TCRR

Tcr2 Therapeutics Inc.

10% owner Morana Jovan-Embiricos sold $1.1M of Tcr2 Therapeutics Inc.

Sold$1,097,080
$17.11Price
64,104Shares
−2%Stake

What TCRR did after the filing

Prices for TCRR after this filing aren't in yet.

Traded Wed, Aug 21. Filed Thu, Sep 5, 12:32 PM ET, during the session. Not investment advice.